OpenVSafe by OpenVAERS
Search V-safe

HF2-15119-71393

3 vaccinations 2 coded responses 14 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
902 / CA
Registered
2022-01-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Moderna
  2. 2021-04-22
    Dose 2 — Moderna
  3. 2022-01-13
    Registered in v-safe
  4. 2022-01-13
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-13
    Health check-in — day 0, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2022-01-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  7. 2022-01-15
    Survey response — days 1–6 daily, dose 3
    MedDRA: Asthma, Pre-existing disease — Feeling: Good · Site: Pain
    Free text: My asthma acted up last night, used my inhaler and I was fine
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-01-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2022-01-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2022-01-20
    Health check-in — day 7, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2022-01-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-02-03
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-02-10
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-02-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-02-24
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-04-16
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-07-16
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  18. 2023-01-13
    Survey response — 12 months, dose 3
    MedDRA: Sinusitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  19. 2023-01-13
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  20. 2023-01-16

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Moderna No
22021-04-22Moderna No
32022-01-13Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2022-01-15

Systemic reaction (other): My asthma acted up last night, used my inhaler and I was fine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDSinusitis · · ✓
SROAsthma · · ✓
SROPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release